These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6763463)

  • 1. [Sensitization of guinea pigs with L and S forms of Proteus mirabilis D52].
    Toshkov A; Kenarova B; Ivanova E; Gumpert I
    Acta Microbiol Bulg; 1982; 11():86-90. PubMed ID: 6763463
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant activity of the Escherichia coli WF table L-form cytoplasmic membranes.
    Ivanova E; Kenarova B; Gumpert J
    Acta Microbiol Bulg; 1993; 29():54-60. PubMed ID: 8511999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of enterobacterial common antigen: Proteus mirabilis and its various L-forms.
    Rinno J; Gmeiner J; Golecki JR; Mayer H
    J Bacteriol; 1980 Feb; 141(2):822-7. PubMed ID: 6154039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and immunochemical studies on the lipopolysaccharide of the 'T-antigen'-containing mutant Proteus mirabilis R14/1959.
    Bartodziejska B; Radziejewska-Lebrecht J; Lipinska M; Knirel YA; Kononov LO; Chernyak AY; Mayer H; Rozalski A
    FEMS Immunol Med Microbiol; 1996 Feb; 13(2):113-21. PubMed ID: 8731019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenic properties on mice of cell-wall-deficient Brucella (L-forms).
    Schmitt-Slomska J; Caravano R; Starka G; Mauss H; Drach G; Lemaire J
    Dev Biol Stand; 1984; 56():187-97. PubMed ID: 6489614
    [No Abstract]   [Full Text] [Related]  

  • 6. [Researches on some biochemical and serological properties and on the sensitivity to antibiotics of L-forms of "Proteus" (author's transl)].
    Barbuti S; Montagna MT; Quarto M
    Ann Sclavo; 1979; 21(4):456-67. PubMed ID: 400087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Total protein amino acid composition of bacterial and stable L forms of Proteus mirabilis D52].
    Ivanova E; Toshkov A; Sotirov N; Gumpert J
    Acta Microbiol Bulg; 1984; 15():24-30. PubMed ID: 6385639
    [No Abstract]   [Full Text] [Related]  

  • 8. [The isolation of a transfer factor of the delayed-hypersensitivity type to the antigenic substances of Staphylococcus aureus in guinea pigs].
    Holieva OH; Liubchenko TA; Kholodna LS; Vershihora AIu
    Fiziol Zh (1994); 1996; 42(5-6):58-65. PubMed ID: 9044813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The primary response to LPS and lipid A of P. mirabilis at the cellular level.
    Kotelko K; Gościcka T; Rubinkiewicz H; Szer K; Krajewska D
    Bull Acad Pol Sci Biol; 1975; 23(12):777-83. PubMed ID: 766920
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serologic studies of cross reactions between strains of Proteus mirabilis OXK (prO 10/52) and Proteus mirabilis S1959].
    Swierzko AS; Cedzyński M; Ziółkowski A; Kaca W
    Postepy Hig Med Dosw; 1996; 50(5):507-9. PubMed ID: 9072766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The experimental myocarditis of mice immunized with group A streptococcal cytoplasmic membrane fraction extracted from L-forms.
    Matsunaga K; Katoh K; Takahashi T; Sakamoto H; Tani K; Okuda K; Tadokoro I; Kitamura H
    Jpn J Exp Med; 1982 Oct; 52(5):267-70. PubMed ID: 6763085
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antigenic characteristics of the L forms of hemolytic Streptococcus group A].
    Goncharova SA; Chumachenko NV; Sonina NV; Kagan GIa
    Mikrobiol Zh (1978); 1980; 42(2):205-13. PubMed ID: 6155594
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cross-reacting antigens of human thymus myoid cells and stable L-forms of group A streptococci].
    Beletskaia LV; Vul'fovich IuV; Gnezditskaia EV; Goncharova SA
    Biull Eksp Biol Med; 1981 Jun; 91(6):704-6. PubMed ID: 6168315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electron microscopy studies of complex of proteocin D52 Proteus mirabilis and antibody.
    Kretova AF; Popova GA; Tikhonenko AS
    Immunochemistry; 1971 Nov; 8(11):1007-10. PubMed ID: 4110100
    [No Abstract]   [Full Text] [Related]  

  • 15. [Characteristics of "supersound" antigens of Proteus mirabilis].
    Ielshina MO; Omel'ianets' TH; Open'ko LV; Dykhovychna DIe; Lukach IH
    Mikrobiol Zh; 1976; 38(6):756-60. PubMed ID: 794647
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of antigenic properties of flagella and flagellins of Proteus mirabilis and its R mutant.
    Izdebska-Szymona K
    Acta Microbiol Pol A; 1974; 6(3):241-51. PubMed ID: 4604250
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization and serological classification of O-specific polysaccharide of Proteus mirabilisTG 276-90 from Proteus serogroup O34.
    Kołodziejska K; Siwińska M; Zych K; Rózalski A; Sidorczyk Z
    Arch Immunol Ther Exp (Warsz); 2006; 54(3):223-6. PubMed ID: 16736109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Protective properties of antigenic complexes of Proteus].
    Kreĭnin LS; Kaverina KG; Aksenova EV; Buatkova LIu
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Jan; (1):60-4. PubMed ID: 7015763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Obtaining antisera to Pseudomonas aeruginosa and Proteus antigens for performing immunoenzyme analyses in clinical practice].
    Bulava GV; Ermolin GA
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Jan; (1):51-5. PubMed ID: 3920845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulation by corynebacterium parvum in two strains of guinea-pigs and the effect of cyclophosphamide.
    Gauthier-Rahman S
    Immunology; 1981 Jan; 42(1):99-109. PubMed ID: 7461727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.